Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NYSE: LCTX) | Delayed: 1.00 +0.01 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.99 | 52 Week High | $ | |||
| Open | $0.97 | 52 Week Low | $ | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $ | |||
| Volume | 1,150,157 | |||||
| (NYSE: LCTX) | Delayed: 1.00 +0.01 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.99 | 52 Week High | $ | |||
| Open | $0.97 | 52 Week Low | $ | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $ | |||
| Volume | 1,150,157 | |||||
